Britain's medicines regulator said on Friday it had extended approval of the COVID-19 vaccine developed by Pfizer (PFE.N) and BioNTech (22UAy.DE) so it can be used on 12- to 15-year-olds.
Published 5 سال قبل on جون 5 2021، 6:33 صبح
By Web Desk
"We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer/BioNTech COVID-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk," June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency, said.
She added that it would be up to the Joint Committee on Vaccination and Immunisation to decide whether this age group would come under the vaccine deployment programme.
Courtesy: Reuters
Here’s how journalists spot deepfakes
- 9 گھنٹے قبل
Field Marshal Asim Munir,Saudi Minister discuss security situation
- 6 گھنٹے قبل
PM Shebaz directs austerity, savings strategy amid global economic pressures
- 2 گھنٹے قبل
Aus GP: Aston Martin participation in doubt
- 6 گھنٹے قبل
Aus GP: Leclerc tops FP1 ahead of Hamilton
- 6 گھنٹے قبل
Berger's 63 wows at Bay Hill; JT returns with 79
- 6 گھنٹے قبل
Canes get commitment from 2027 4-star WR Lennear
- 6 گھنٹے قبل
Daly's son shoots 70 in Tour debut in Puerto Rico
- 6 گھنٹے قبل
Pakistan's armed forces continue operations against Afghan Taliban, Fitna al Khawarij
- 6 گھنٹے قبل
Security forces conduct successful operations in Balochistan, 15 terrorists killed:ISPR
- 4 گھنٹے قبل
Boston 2026 backs Foxborough WC security costs
- 6 گھنٹے قبل
DPM, UAE FM discuss evolving regional situation
- 2 گھنٹے قبل
You May Like
Trending
